Regulation of leptin by agouti

Physiological Genomics

Volumn 2000, Issue 2, 2000, Pages 101-105

  Claycombe, Kate J ^a   Xue, Bing Zhong ^a   Mynatt, Randall L ^b   Zemel, Michael B ^a   Moustaid Moussa, Naima ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

^b PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

3T3 L1 cells; Adipocyte; Insulin; Transgenic mice

Indexed keywords

AGOUTI; MUS MUSCULUS;

ACTIVATOR PROTEIN 2 BINDING ELEMENT; ACTIVATOR PROTEIN-2 BINDING ELEMENT; AGOUTI PROTEIN; CARRIER PROTEIN; CORTICOTROPIN RECEPTOR; DNA BINDING PROTEIN; FABP5 PROTEIN, MOUSE; FABP7 PROTEIN, MOUSE; FATTY ACID BINDING PROTEIN; INSULIN; INTERMEDIN; LEPTIN; MELANOCORTIN 4 RECEPTOR; MELANOCORTIN RECEPTOR; MESSENGER RNA; N ACETYL ALPHA INTERMEDIN[4-10]CYCLO[4 NORLEUCINE 5 ASPARTIC ACID 7 [3 (2 NAPHTHYL)ALANINE] 10 LYSINAMIDE]; NERVE PROTEIN; PROTEIN; RECEPTOR; SIGNAL PEPTIDE; TUMOR PROTEIN;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL; ARTICLE; BLOOD; CELL CULTURE; CHEMISTRY; CYTOLOGY; DIABETES MELLITUS; DRUG ADMINISTRATION; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; GENETICS; HOMOZYGOTE; MALE; METABOLISM; MOUSE; OBESITY; PROMOTER REGION; SUBCUTANEOUS DRUG ADMINISTRATION; TRANSGENIC MOUSE;

ADIPOCYTES; ADIPOSE TISSUE; ANIMALS; CARRIER PROTEINS; CELLS, CULTURED; DIABETES MELLITUS; DNA-BINDING PROTEINS; DRUG ADMINISTRATION SCHEDULE; FATTY ACID-BINDING PROTEINS; HOMOZYGOTE; INJECTIONS, SUBCUTANEOUS; INSULIN; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LEPTIN; MALE; MELANOCYTE-STIMULATING HORMONES; MICE; MICE, TRANSGENIC; NEOPLASM PROTEINS; NERVE TISSUE PROTEINS; OBESITY; PROMOTER REGIONS (GENETICS); PROTEINS; RECEPTOR, MELANOCORTIN, TYPE 4; RECEPTORS, CORTICOTROPIN; RECEPTORS, MELANOCORTIN; RECEPTORS, PEPTIDE; RNA, MESSENGER;

EID: 0034720023     PISSN: 15312267     EISSN: None     Source Type: Journal    
DOI: 10.1152/physiolgenomics.2000.2.3.101     Document Type: Article

References (33)

1. Barr VA, Malide D, Zarnowski MJ, Taylor SI, and Cushman SW. Insulin stimulates both leptin secretion and production by rat white adipose tissue. Endocrinology 138: 4463-4472, 1997.
2. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1996.
3. Bultman SJ, Russell LB, Gutierrez-Espeleta GA, and Woychik RP. Molecular characterization of a region of DNA associated with mutations at the agouti locus in the mouse. Proc Natl Acad Sci USA 88: 8062-8066, 1991.
4. Capro S, Tamborlane WV, Silver D, Robinson C, Leibel R, McCarthy S, Grozman A, Belous A, Maggs D, and Sherwin RS. Hyperleptinemia: an early sign of juvenile obesity. Relations to fat depots and insulin concentrations. Am J Physiol Endocrinol Metab 271: E626-E630, 1996.
5. Chagnon YC, Chen WJ, Perusse L, Chagnon M, Nadeau A, Wilkison WO, and Bouchard C. Linkage and association studies between the melanocortin receptors 4 and 5 genes and obesity-related phenotypes in the Quebec family study. Mol Med 3: 663-673, 1997.
6. Chessler SD, Fujimoto WY, Shofer JB, Byco EJ, and Weigle DS. Increased plasma leptin levels are associated with fat accumulation in Japanese Americans. Diabetes 47: 239-243, 1998.
7. Frederich RC, Lollmann B, Hamann A, Napolitano-Rosen A, Kahn BB, Lowell BB, and Flier JS. Expression of ob mRNA and its encoded protein in rodents. Impact of nutrition and obesity. J Clin Invest 96: 1658-1663, 1995.
8. Halaas JL, Boozer C, Blair-West J, Fidahusein N, Denton DA, and Friedman JM. Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. Proc Natl Acad Sci USA 94: 8878-8883, 1997.
9. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, and Friedman JM. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269: 543-546, 1995.
10. Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR, Gu W, Keterson RA, Boston BA, Cone RD, Smith FJ, Campfield LA, Burn P, and Lee F. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88: 131-141, 1997.
11. Jackson IJ. Mouse coat colour mutations: a molecular genetic resource, which spans the centuries. Bioessays 13: 439-446, 1991.
12. Jones BH, Kim JH, Zemel MB, Woychik RP, Michaud ED, Wilkison WO, and Moustaid N. Upregulation of adipocyte metabolism by agouti protein: possible paracrine actions in yellow mouse obesity. Am J Physiol Endocrinol Metab 270: E192-E196, 1996.
13. Jones BH, Standridge M, and Moustaïd N. Angiotensin II increases lipogenesis in 3T3-L1 and human adipose cells. Endocrinology 138: 1512-1519, 1997.
14. Klebig ML, Wilkinson JE, Geisler JG, and Woychik RP. Ectopic expression of the agouti gene in transgenic mice causes obesity, features of type II diabetes, and yellow fur. Proc Natl Acad Sci USA 92: 4728-4732, 1995.
15. Kolaczynski JW, Nyce MR, Considine RV, Boden G, Nolan JJ, Henry R, Mudaliar SR, Olefsky J, and Caro JF. Acute and chronic effects of insulin on leptin production in humans: Studies in vivo and in vitro. Diabetes 45: 699-701, 1996.
16. Kolacznski JW, Ohannenesian JP, Considine RV, Marco CC, and Caro JF. Response of leptin to short-term and prolonged overfeeding in humans. J Clin Endocrinol Metab 81: 4162-4165, 1996.
17. Kwon HY, Bultman SJ, Loffeler C, Chen W, Furdon PJ, Powell JG, Usala AL, Wilkison WO, Hansmann I, and Woychick RP. Molecular structure and chromosomal mapping of the human homolog of the agouti gene. Proc Natl Acad Sci USA 91: 9760-9764, 1994.
18. Lu D, Willard D, Patel IR, Kadwell S, Overton L, Kost T, Luther M, Chen W, Woychik R, and Wilkison WO. Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor. Nature 371: 799-802, 1994.
19. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, and Ranganathan S. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1: 1155-1161, 1995.
20. Moustaïd-Moussa N and Claycombe K. Mechanisms of agouti-induced obesity. Obes Res 7: 506-514, 1999.
21. Moustaid N and Sul HS. Regulation of expression of the fatty acid synthase gene in 3T3L-1 cells by differentiation and triiodothyronine. J Biol Chem 266: 18550-18554, 1991.
22. Mynatt RL, Miltenberger RJ, Klebig ML, Zemel MB, Wilkinson JE, Wilkison WO, and Woychik RP. Combined effects of insulin treatment and adipose tissue-specific agouti expression on the development of obesity. Proc Natl Acad Sci USA 94: 919-922, 1997.
23. Pratley RE, Nicolson M, Bogardus C, and Ravussin E. Effects of acute hyperinsulinemia on plasma leptin concentrations in insulin-sensitive and insulin-resistant Pima Indians. J Clin Endocrinol Metab 81: 4418-4421, 1996.
24. Ranganathan S, Maffei M, and Kern PA. Adipose tissue ob mRNA expression in human: discordance with plasma leptin and relationship with adipose TNF alpha expression. J Lipid Res 39: 724-730, 1988.
25. Rentsch J and Chiesi M. Regulation of ob gene mRNA levels in cultured adipocytes. FEBS Lett 379: 55-59, 1996.
26. Rossi M, Kim MS, Morgan DG, Small CJ, Edwards CM, Sunter D, Abusnana S, Goldstone AP, Russell SH, Stanley SA, Smith DM, Yagaloff K, Ghatei MA, and Bloom SR. A C-terminal fragment of Agouti-related protein increases feeding and antagonizes the effect of alpha-melanocyte stimulating hormone in vivo. Endocrinology 139: 4428-4431, 1998.
27. Ryan AS and Elahi D. The effects of acute hyperglycemia and hyperinsulinemia on plasma leptin levels: its relationships with body fat, visceral adiposity, and age in women. J Clin Endocrinol Metab 81: 4433-4438, 1996.
28. Schwartz MW, Seeley RJ, Woods SC, Weigle DS, Campfield LA, Burn P, and Baskin DG. Leptin increases hypothalamic pro-opiomelanocortin mRNA expression in the rostral arcuate nucleus. Diabetes 46: 2119-2123, 1997.
29. Seeley RJ, Yagaloff KA, Fisher SL, Burn P, Thieele TE, van Dijk G, Baskin DG, and Schwartz M. Melanocortin receptors in leptin effects. Nature 390: 349, 1997.
30. Siegrist-Kaiser CA, Pauli V, Juge-Aubry CE, Boss O, Pernin A, Chin WW, Cusin I, Rohner-Jeanrenaud F, Burger AG, Zapf J, and Meier CA. Direct effects of leptin on brown and white adipose tissue. J Clin Invest 100: 2858-2864, 1997.
31. 2+-dependent mechanism. FASEB J 12: 1391-1396, 1998.
32. vy)/-mice: ectopic expression of the agouti gene. FASEB J 8: 479-488, 1994.
33. Zemel MB, Moore JW, Moustaïd N, Parks D, Blanchard S, and Wilkison WO. Effects of a potent melanocortin agonist on the diabetic/obese phenotype in yellow mice. Int J Obes 22: 678-683, 1998.